In this study, we reveal new highlights that GEM functions as a suppressor of PARP-1 by promoting the autophagy degradation pathway and put forward the related suggestions about the desired characteristics of possible candidates for combination therapy with GEM for PC. The gene discussed is PARP1; the disease is pachyonychia congenita.